Cost effectiveness of direct-acting antiviral therapy for treatment-naive patients with chronic HCV genotype 1 infection in the veterans health administration.

PubWeight™: 1.19‹?› | Rank: Top 10%

🔗 View Article (PMID 23707354)

Published in Clin Gastroenterol Hepatol on May 22, 2013

Authors

Kee Chan1, Mai Ngan Lai, Erik J Groessl, Amresh D Hanchate, John B Wong, Jack A Clark, Steven M Asch, Allen L Gifford, Samuel B Ho

Author Affiliations

1: Department of Health Sciences, College of Health and Rehabilitation Sciences, Sargent College, Boston University, Boston, Massachusetts; Department of Epidemiology, School of Public Health, Boston University, Boston, Massachusetts; VA HIV/Hepatitis Quality Enhancement Research Initiative, Edith Nourse Rogers Memorial Veterans Hospital, Bedford, Massachusetts.

Articles citing this

Effectiveness of exome and genome sequencing guided by acuity of illness for diagnosis of neurodevelopmental disorders. Sci Transl Med (2014) 3.28

The treatment cascade for chronic hepatitis C virus infection in the United States: a systematic review and meta-analysis. PLoS One (2014) 1.58

The hepatitis C cascade of care: identifying priorities to improve clinical outcomes. PLoS One (2014) 1.25

Costs of telaprevir-based triple therapy for hepatitis C: $189,000 per sustained virological response. Hepatology (2014) 1.05

Ribavirin induced anaemia: the effect of vitamin D supplementation on erythropoietin and erythrocyte indices in normal Wistar rat. Int J Clin Exp Med (2014) 0.87

Activins and Follistatin in Chronic Hepatitis C and Its Treatment with Pegylated-Interferon-α Based Therapy. Mediators Inflamm (2015) 0.82

Present, old and future strategies for anti-HCV treatment in patients infected by genotype-1: estimation of the drug costs in the Calabria Region in the era of the directly acting antivirals. BMC Infect Dis (2014) 0.79

Serum Activins and Follistatin during the Treatment of Chronic Hepatitis C Genotypes 1 and 4 and Their Correlations with Viral Load and Liver Enzymes: A Preliminary Report. Gastroenterol Res Pract (2014) 0.79

Why We Should Be Willing to Pay for Hepatitis C Treatment. Clin Gastroenterol Hepatol (2015) 0.79

Cost-effectiveness of new antiviral regimens for treatment-naïve U.S. veterans with hepatitis C. Hepatology (2015) 0.79

Value of Treating All Stages of Chronic Hepatitis C: A Comprehensive Review of Clinical and Economic Evidence. Infect Dis Ther (2016) 0.79

Hepatitis C virus: A time for decisions. Who should be treated and when? World J Gastrointest Pharmacol Ther (2016) 0.76

Vitamin D Status and Virologic Response to HCV Therapy in the HALT-C and VIRAHEP-C Trials. PLoS One (2016) 0.76

Vitamin D and chronic hepatitis C: effects on success rate and prevention of side effects associated with pegylated interferon-α and ribavirin. Int J Clin Exp Med (2015) 0.76

Hepatitis C virus infection: from margin to center in rhode island and beyond. R I Med J (2013) (2014) 0.75

Mortality, Hospitalization, and Quality of Life among Patients with Hepatitis C Infection on Hemodialysis. Clin J Am Soc Nephrol (2016) 0.75

Impact of hepatitis C virus core mutations on the response to interferon-based treatment in chronic hepatitis C. World J Gastroenterol (2016) 0.75

The effects of pegylated interferon-α and ribavirin on liver and serum concentrations of activin-A and follistatin in normal Wistar rat: a preliminary report. BMC Res Notes (2015) 0.75

Viral hepatitis: Cost-effectiveness of direct-acting antivirals for chronic hepatitis C. Nat Rev Gastroenterol Hepatol (2013) 0.75

Articles by these authors

The quality of health care delivered to adults in the United States. N Engl J Med (2003) 50.33

Incidence and economic burden of osteoporosis-related fractures in the United States, 2005-2025. J Bone Miner Res (2007) 14.84

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update. Ann Rheum Dis (2013) 10.92

Retention in care: a challenge to survival with HIV infection. Clin Infect Dis (2007) 10.66

Effect of Vitamin D on falls: a meta-analysis. JAMA (2004) 6.64

Fracture prevention with vitamin D supplementation: a meta-analysis of randomized controlled trials. JAMA (2005) 5.95

Physician-related barriers to the effective management of uncontrolled hypertension. Arch Intern Med (2002) 5.80

Prevention of nonvertebral fractures with oral vitamin D and dose dependency: a meta-analysis of randomized controlled trials. Arch Intern Med (2009) 5.63

Early virologic response to treatment with peginterferon alfa-2b plus ribavirin in patients with chronic hepatitis C. Hepatology (2003) 5.40

Meta-analysis: the effect of dietary counseling for weight loss. Ann Intern Med (2007) 4.54

Estimating hip fracture morbidity, mortality and costs. J Am Geriatr Soc (2003) 4.44

Substance use and mental health correlates of nonadherence to antiretroviral medications in a sample of patients with human immunodeficiency virus infection. Am J Med (2003) 3.81

Relationship between number of medical conditions and quality of care. N Engl J Med (2007) 3.78

Comparative effectiveness of pharmacologic interventions for knee osteoarthritis: a systematic review and network meta-analysis. Ann Intern Med (2015) 3.75

The implications of choice: prescribing generic or preferred pharmaceuticals improves medication adherence for chronic conditions. Arch Intern Med (2006) 3.64

You are where you shop: grocery store locations, weight, and neighborhoods. Am J Prev Med (2006) 3.33

Patient-reported measures of health: The Veterans Health Study. J Ambul Care Manage (2004) 3.30

Trends in the use and capacity of California's emergency departments, 1990-1999. Ann Emerg Med (2002) 3.26

Calcium intake and hip fracture risk in men and women: a meta-analysis of prospective cohort studies and randomized controlled trials. Am J Clin Nutr (2007) 3.14

Effect of emergency department crowding on outcomes of admitted patients. Ann Emerg Med (2012) 3.13

A prospective study of neuropsychiatric symptoms associated with interferon-alpha-2b and ribavirin therapy for patients with chronic hepatitis C. Psychosomatics (2003) 3.10

Prospective multicenter study of eligibility for antiviral therapy among 4,084 U.S. veterans with chronic hepatitis C virus infection. Am J Gastroenterol (2005) 3.09

Epilepsy surgery for pharmacoresistant temporal lobe epilepsy: a decision analysis. JAMA (2008) 3.01

Intestinal goblet cells and mucins in health and disease: recent insights and progress. Curr Gastroenterol Rep (2010) 2.93

Model transparency and validation: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force--7. Value Health (2012) 2.86

Exploring barriers and facilitators to the use of computerized clinical reminders. J Am Med Inform Assoc (2005) 2.82

Development of national and multiagency HIV care quality measures. Clin Infect Dis (2010) 2.79

Posttraumatic stress disorder and risk of spontaneous preterm birth. Obstet Gynecol (2014) 2.71

Clinical quality measures for electrodiagnosis in suspected carpal tunnel syndrome. Muscle Nerve (2010) 2.71

Increasing prevalence of HCC and cirrhosis in patients with chronic hepatitis C virus infection. Gastroenterology (2010) 2.64

Quality of care in patients with chronic hepatitis C virus infection: a cohort study. Ann Intern Med (2010) 2.44

Human factors barriers to the effective use of ten HIV clinical reminders. J Am Med Inform Assoc (2003) 2.42

Individualizing quality-of-life outcomes reporting: how localized prostate cancer treatments affect patients with different levels of baseline urinary, bowel, and sexual function. J Clin Oncol (2009) 2.40

Estimating the proportion of patients infected with HIV who will die of comorbid diseases. Am J Med (2005) 2.38

Chronic exposure to beta-blockers attenuates inflammation and mucin content in a murine asthma model. Am J Respir Cell Mol Biol (2007) 2.24

Costs and benefits of targeted screening for causes of sudden cardiac death in children and adolescents. Circulation (2012) 2.24

Compliance among pharmacies in California with a prescription-drug discount program for Medicare beneficiaries. N Engl J Med (2002) 2.22

Underdiagnosis of depression in HIV: who are we missing? J Gen Intern Med (2003) 2.21

Model transparency and validation: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force-7. Med Decis Making (2012) 2.21

An explicit quality indicator set for measurement of quality of care in patients with cirrhosis. Clin Gastroenterol Hepatol (2010) 2.18

Patient-reported long-term outcomes after conventional and high-dose combined proton and photon radiation for early prostate cancer. JAMA (2010) 2.16

Identifying barriers to the effective use of clinical reminders: bootstrapping multiple methods. J Biomed Inform (2004) 2.15

A meta-analysis of randomized controlled trials comparing coronary artery bypass graft with percutaneous transluminal coronary angioplasty: one- to eight-year outcomes. J Am Coll Cardiol (2003) 2.10

Measuring pain as the 5th vital sign does not improve quality of pain management. J Gen Intern Med (2006) 2.04

Surgery for hepatocellular carcinoma: does it improve survival? Ann Surg Oncol (2004) 2.01

Controversies and legal issues of prescribing and dispensing medications using the Internet. Mayo Clin Proc (2004) 1.99

Waiting times in California's emergency departments. Ann Emerg Med (2003) 1.95

A systematic review of stakeholder engagement in comparative effectiveness and patient-centered outcomes research. J Gen Intern Med (2014) 1.93

Quality of care for gout in the US needs improvement. Arthritis Rheum (2007) 1.93

Quality of colonoscopy withdrawal technique and variability in adenoma detection rates (with videos). Gastrointest Endosc (2011) 1.93

Measuring persistence of implementation: QUERI Series. Implement Sci (2008) 1.92

Variation in implementation and use of computerized clinical reminders in an integrated healthcare system. Am J Manag Care (2004) 1.91

Cash and compassion: profit status and the delivery of hospice services. J Palliat Med (2002) 1.86

Lifestyle Interventions and Independence for Elders pilot study: recruitment and baseline characteristics. J Am Geriatr Soc (2007) 1.86

Body mass index, neighborhood fast food and restaurant concentration, and car ownership. J Urban Health (2009) 1.86

The quality of pharmacologic care for adults in the United States. Med Care (2006) 1.85

How well do clinicians estimate patients' adherence to combination antiretroviral therapy? J Gen Intern Med (2002) 1.84

ACCF/AHA/AMA-PCPI 2011 performance measures for adults with heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures and the American Medical Association-Physician Consortium for Performance Improvement. Circulation (2012) 1.82

What do you mean, a spot?: A qualitative analysis of patients' reactions to discussions with their physicians about pulmonary nodules. Chest (2013) 1.79

Dysbiosis-induced intestinal inflammation activates tumor necrosis factor receptor I and mediates alcoholic liver disease in mice. Hepatology (2015) 1.76

Lifestyle interventions and independence for elders study: recruitment and baseline characteristics. J Gerontol A Biol Sci Med Sci (2013) 1.75

Organ conservation in invasive bladder cancer by transurethral resection, chemotherapy and radiation: results of a urodynamic and quality of life study on long-term survivors. J Urol (2003) 1.74

Measuring the quality of colorectal cancer screening: the importance of follow-up. Dis Colon Rectum (2006) 1.72

The quality of care provided to patients with cirrhosis and ascites in the Department of Veterans Affairs. Gastroenterology (2012) 1.71

Comparing the health status of VA and non-VA ambulatory patients: the veterans' health and medical outcomes studies. J Ambul Care Manage (2004) 1.70

Alcohol use and treatment of hepatitis C virus: results of a national multicenter study. Gastroenterology (2006) 1.70

Expanded criteria donor grafts for deceased donor liver transplantation under the MELD system: a decision analysis. Liver Transpl (2004) 1.69

ACCF/AHA/AMA-PCPI 2011 performance measures for adults with coronary artery disease and hypertension: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures and the American Medical Association-Physician Consortium for Performance Improvement. J Am Coll Cardiol (2011) 1.69

Improving HIV screening and receipt of results by nurse-initiated streamlined counseling and rapid testing. J Gen Intern Med (2008) 1.67

Quality of health care for women: a demonstration of the quality assessment tools system. Med Care (2003) 1.66

Empirical anti-Candida therapy among selected patients in the intensive care unit: a cost-effectiveness analysis. Ann Intern Med (2005) 1.66

Predictors of retention in HIV care among a national cohort of US veterans. HIV Clin Trials (2009) 1.65

Development and initial validation of the PEG, a three-item scale assessing pain intensity and interference. J Gen Intern Med (2009) 1.62

Optimizing measurement of self-reported adherence with the ACTG Adherence Questionnaire: a cross-protocol analysis. J Acquir Immune Defic Syndr (2007) 1.62

Effectiveness and Implications of Alternative Placebo Treatments: A Systematic Review and Network Meta-analysis of Osteoarthritis Trials. Ann Intern Med (2015) 1.61

Impact of clinical reminder redesign on learnability, efficiency, usability, and workload for ambulatory clinic nurses. J Am Med Inform Assoc (2007) 1.59

Racial differences in how patients perceive physician communication regarding cardiac testing. Med Care (2002) 1.58

Chronic disease self-management and adherence to HIV medications. J Acquir Immune Defic Syndr (2002) 1.58

Predicting the probability of progression-free survival in patients with small hepatocellular carcinoma. Liver Transpl (2002) 1.57

Comparing the public health burden of chronic hepatitis C and HIV infection in France. J Hepatol (2004) 1.57

Differential immune responses and pulmonary pathophysiology are induced by two different strains of respiratory syncytial virus. Am J Pathol (2006) 1.55

Predictors of treatment in patients with chronic hepatitis C infection - role of patient versus nonpatient factors. Hepatology (2007) 1.55

Respiratory syncytial virus infection in the absence of STAT 1 results in airway dysfunction, airway mucus, and augmented IL-17 levels. J Allergy Clin Immunol (2005) 1.52

The effect of Massachusetts health reform on 30 day hospital readmissions: retrospective analysis of hospital episode statistics. BMJ (2014) 1.52

Treatment 'mismatch' in early prostate cancer: do treatment choices take patient quality of life into account? Cancer (2008) 1.51

Time course and predictors of symptoms after primary prostate cancer therapy. J Clin Oncol (2003) 1.51

Patient, physician, pharmacy, and pharmacy benefit design factors related to generic medication use. J Gen Intern Med (2007) 1.50

Embracing a health services research perspective on personal health records: lessons learned from the VA My HealtheVet system. J Gen Intern Med (2010) 1.50

Barriers and facilitators to routine HIV testing in VA primary care. J Gen Intern Med (2009) 1.48

Is it influenza or anthrax? A decision analytic approach to the treatment of patients with influenza-like illnesses. Ann Emerg Med (2004) 1.48

Sins of omission: getting too little medical care may be the greatest threat to patient safety. J Gen Intern Med (2005) 1.48

Racial differences in cardiac catheterization as a function of patients' beliefs. Am J Public Health (2004) 1.47

The challenge of measuring quality of care from the electronic health record. Am J Med Qual (2009) 1.47

A system-wide intervention to improve HIV testing in the Veterans Health Administration. J Gen Intern Med (2008) 1.46

Psychosocial mediators of antiretroviral nonadherence in HIV-positive adults with substance use and mental health problems. Health Psychol (2004) 1.46

A meta-analytic comparison of echocardiographic stressors. Int J Cardiovasc Imaging (2005) 1.46